Dual chamber leadless pacemaker - Notified Bodfy 123 - 28/03/2024 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Submitted by Anonymous (not verified) on 17 July 2026 - 15:03

Dual chamber leadless pacemaker - Notified Bodfy 123 - 28/03/2024 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment

Submitted by Anonymous (not verified) on 17 July 2026 - 15:00

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment

Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 17 July 2026 - 15:00

Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Terms of reference for the European Medicines Agency, Health Canada and United States Food and Drug Administration cluster on blood products

Submitted by Anonymous (not verified) on 17 July 2026 - 14:58

Terms of reference for the European Medicines Agency, Health Canada and United States Food and Drug Administration cluster on blood products

Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 17 July 2026 - 14:52

Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 4, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness